Tandem Diabetes Care (TNDM) Cash from Operations (2013 - 2026)

Tandem Diabetes Care has reported Cash from Operations for 14 years, with the latest figure at 11054000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 160.48% year-over-year to 11054000.0; the trailing twelve-month figure through Mar 2026 stood at 19611000.0 (up 40.65% YoY), and the FY2025 full-year result was 9721000.0, down 140.13% from the prior year.
• Cash from Operations for Q1 2026 stood at 11054000.0, up from 9789000.0 in the prior quarter.
• The five-year high for Cash from Operations was 26779000.0 in Q3 2024, with the low at 18326000.0 in Q1 2023.
• Historically, Cash from Operations has averaged 2600705.88 across 5 years, with a median of 5820000.0 in 2022.
• Annual changes were most pronounced in 2023 — Cash from Operations sank 232.8% — and 2024, when it surged 48589.09%.
• Tandem Diabetes Care's Cash from Operations stood at 5820000.0 in 2022, then sank by 223.99% to 7216000.0 in 2023, then surged by 248.52% to 10717000.0 in 2024, then dropped by 8.66% to 9789000.0 in 2025, then climbed by 12.92% to 11054000.0 in 2026.
• The last three Cash from Operations figures came in at 11054000.0 (Q1 2026), 9789000.0 (Q4 2025), and 8264000.0 (Q3 2025), per Business Quant data.